Syncona Limited (SYNC) Ordinary NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
99.50p
100.82p
131.60p
178.95
99.50p
99.50p
99.40p
-44.40%
0.30p (0.30%) Previous:
0.30p
482,080
n/a
GBX
Price
-
Net Asset Value (NAV)
Performance
1 week 1W | 10.66% | 1 year 1Y | 16.22% |
---|---|---|---|
1 month 1M | 8.53% | 2 years 2Y | 46.63% |
3 months 3M | 17.47% | 3 years 3Y | 52.52% |
6 months 6M | 11.14% | 5 years 5Y | 54.89% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Trust Basics
Benchmark: | FTSE 250 TR GBP |
---|---|
Annual management charge: | n/a |
Performance fee: | No |
Ongoing charge: | 1.74% |
Dividend yield: | n/a |
Dividend frequency: | Annually |
Total assets: | £1,131m |
Gross gearing: | 0% |
Market capitalisation:Market cap.: | £629m |
Shares in issue: | 632.02 million |
Legal structure | Closed Ended Investment Company |
Domicile: | Guernsey |
ISIN | GG00B8P59C08 |
Dividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
Objective
NET ASSET VALUE (NAV)
Estimated NAV: | 178.95p |
---|---|
Latest actual NAV: | 178.95p |
Latest actual NAV date: | 30 September 2024 |
Premium/Discount: | -44.40% |
12m average Premium/Discount: | -35.95% |
NAV frequency: | Quarterly |
Security | Weight |
---|---|
Capital Pool | 30.81% |
Spur Therapeutics | 13.76% |
Beacon Therapeutics | 9.87% |
Autolus Therapeutics PLC ADR | 7.29% |
Quell Therapeutics | 6.99% |
Resolution Therapeutics | 5.56% |
Purespring Therapeutics | 4.47% |
Omass Therapeutics | 4.34% |
Anaveon | 3.14% |
Crt Pioneer Fund | 2.89% |
Top 10 sectors currently unavailable.
Country | Weight |
---|---|
United Kingdom | 8.03% |
United States | 0.13% |
Key Dates
Launch date: | 26 October 2012 |
---|---|
Financial year end: | March |
Next AGM: | August 2025 |
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.